Details
Stereochemistry | ACHIRAL |
Molecular Formula | Mg |
Molecular Weight | 24.305 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 2 |
SHOW SMILES / InChI
SMILES
[Mg++]
InChI
InChIKey=JLVVSXFLKOJNIY-UHFFFAOYSA-N
InChI=1S/Mg/q+2
DescriptionSources: http://www.internationalcrystal.net/optics_11.htm | https://www.ncbi.nlm.nih.gov/pubmed/27792982 | https://www.ncbi.nlm.nih.gov/pubmed/26952467 | https://www.ncbi.nlm.nih.gov/pubmed/27995243https://www.scbt.com/scbt/product/magnesium-nitrate-hexahydrate-13446-18-9 | https://www.ncbi.nlm.nih.gov/pubmed/18964415 | https://www.ncbi.nlm.nih.gov/pubmed/2843308http://www.db-pharma.com/anglais/49.pdfhttp://www.sciencedirect.com/science/article/pii/004484868990080Xhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020309s028lbl.pdfhttps://hazmap.nlm.nih.gov/category-details?table=copytblagents&id=1640DOI: 10.2903/j.efsa.2008.883http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3444/pdfdoi: 10.1081/SCC-120022479https://www.xymogen.com/assets/imageDisplay.ashx?productID=111&attachmentTypeID=1https://www.drugs.com/ppa/magnesium-chloride.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/15480451 | https://www.scbt.com/scbt/product/magnesium-iodide-10377-58-9https://www.drugs.com/dosage/magnesium-lactate.htmlhttp://dx.doi.org/10.1155/2015/498932 | http://iicbe.org/upload/4152C514072.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/351265Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9873215 | http://discovery.ucl.ac.uk/1336882/1/1336882.pdf
Sources: http://www.internationalcrystal.net/optics_11.htm | https://www.ncbi.nlm.nih.gov/pubmed/27792982 | https://www.ncbi.nlm.nih.gov/pubmed/26952467 | https://www.ncbi.nlm.nih.gov/pubmed/27995243https://www.scbt.com/scbt/product/magnesium-nitrate-hexahydrate-13446-18-9 | https://www.ncbi.nlm.nih.gov/pubmed/18964415 | https://www.ncbi.nlm.nih.gov/pubmed/2843308http://www.db-pharma.com/anglais/49.pdfhttp://www.sciencedirect.com/science/article/pii/004484868990080Xhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020309s028lbl.pdfhttps://hazmap.nlm.nih.gov/category-details?table=copytblagents&id=1640DOI: 10.2903/j.efsa.2008.883http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3444/pdfdoi: 10.1081/SCC-120022479https://www.xymogen.com/assets/imageDisplay.ashx?productID=111&attachmentTypeID=1https://www.drugs.com/ppa/magnesium-chloride.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/15480451 | https://www.scbt.com/scbt/product/magnesium-iodide-10377-58-9https://www.drugs.com/dosage/magnesium-lactate.htmlhttp://dx.doi.org/10.1155/2015/498932 | http://iicbe.org/upload/4152C514072.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/351265
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9873215 | http://discovery.ucl.ac.uk/1336882/1/1336882.pdf
Struvite, a crystalline substance first identified in the 18th century, is composed of magnesium ammonium
phosphate. Struvite urinary stones are also known as ‘infection stones’, and account for 15%-20% of all urinary stones. Bacterial urease, usually from a Proteus species, is responsible for the chemical changes in urine which result in struvite formation.
CNS Activity
Sources: DOI: 10.1002/0471238961.0218151310010311.a02Vink, R., Mihai Nechifor, M. (2011) 'Magnesium in the Central Nervous System', p.139 Retrieved from https://books.google.ru/books?id=GW0oExaZ7hQChttps://www.drugs.com/mtm/magnesium-lactate.html | https://www.ncbi.nlm.nih.gov/pubmed/27792736 | https://www.ncbi.nlm.nih.gov/pubmed/7669506
Curator's Comment: Magnesium Chloride
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/351265
Curator's Comment: Ulex, a Swedish geologist, is generally credited with introduction of the term struvite in1845
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0001508 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12225296 |
|||
Target ID: GO:0010960 |
|||
Target ID: GO:0033609 |
|||
Target ID: GO:0010960 |
|||
Target ID: P05109 Gene ID: 6279.0 Gene Symbol: S100A8 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8061680 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Preventing | MAGNESIUM SULFATE Approved UseINDICATIONS AND USAGE
Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose. Launch Date1995 |
|||
Primary | MAGNESIUM SULFATE Approved UseINDICATIONS AND USAGE
Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose. Launch Date1995 |
|||
Diagnostic | ColPrep Kit Approved UseINDICATIONS AND USAGE
ColPrep Kit is indicated for cleansing of the colon as a preparation for colonoscopy in adults Launch Date2016 |
|||
Primary | MAGNESIUM SULFATE Approved UseINDICATIONS AND USAGE
Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose. Launch Date1995 |
|||
Curative | MagMin Approved UseMagnesium aspartate (MagMin) is indicated for patients with documented hypomagnesaemia. |
|||
Curative | DELBIASE Approved UseUnknown |
|||
Primary | DELBIASE Approved UseUnknown |
|||
Primary | DELBIASE Approved UseUnknown |
|||
Curative | Magnesium Chloride Approved UseMagnesium Chloride injection is indicated as an electrolyte replenisher in magnesium deficiencies |
|||
Palliative | Magnesium Chloride Approved UseUnknown |
|||
Palliative | Magnesium Chloride Approved UseUnknown |
|||
Primary | EPIMAG Approved UseMagnesium citrate is indicated in cases of oxaluria, to prevent recurrence of calcium oxalate kidney stones. |
|||
Primary | EPIMAG Approved UseUsed to relief of occasional constipation (irregularity). |
|||
Curative | Magnesium Citrate Approved UseMagnesium citrate is indicated to supports magnesium nutritional adequacy. |
|||
Curative | Unknown Approved UseMagnesium lactate is a naturally occurring mineral that is needed in the body to support the function of the heart, nervous system, and digestive system. Magnesium lactate is used as a mineral supplement to treat magnesium deficiency. |
PubMed
Title | Date | PubMed |
---|---|---|
[Magnesium--an alternative in treatment resistant tachyarrhythmias]. | 1977 May 30 |
|
Metal: ATP characteristics of insulin- and epidermal growth factor-stimulated phosphorylation in detergent extracts of rat liver plasma membranes. | 1986 Sep |
|
Metabolism of magnesium and zinc in patients treated with antiepileptic drugs and with magnesium lactate. | 1987 |
|
Decreased intracellular free magnesium in erythrocytes of spontaneously hypertensive rats. | 1987 Mar 30 |
|
Fluorimetry of selenium in body fluids after digestion with nitric acid, magnesium nitrate hexahydrate, and hydrochloric acid. | 1988 Sep |
|
Osteoporosis treated with magnesium lactate. | 1991 |
|
Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. | 1991-1992 |
|
Management of eclampsia. | 1994 Apr |
|
Effect of pyridoxine and magnesium on stress-induced gastric ulcers in mice selected for low or high blood magnesium levels. | 1995 |
|
Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro. | 1996 Jun |
|
Conventional and Eccentric Uses of Crystallographic Databases in Practical Materials Identification Problems. | 1996 May-Jun |
|
Aluminum is a weak agonist for the calcium-sensing receptor. | 1999 May |
|
Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. | 2000 Aug |
|
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. | 2001 Dec 7 |
|
A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients. | 2003 |
|
Interaction of Tl+ with product complexes of fructose-1,6-bisphosphatase. | 2003 May 2 |
|
Ablation of calcitonin/calcitonin gene-related peptide-alpha impairs fetal magnesium but not calcium homeostasis. | 2004 Aug |
|
Low maternal dietary intakes of iron, magnesium, and niacin are associated with spina bifida in the offspring. | 2004 Jun |
|
Structure of pyrimidine 5'-nucleotidase type 1. Insight into mechanism of action and inhibition during lead poisoning. | 2006 Jul 21 |
|
Activation and enzymatic characterization of recombinant human kallikrein 8. | 2006 Jun |
|
Evidence for a two-step mechanism involved in the formation of covalent HC x TSG-6 complexes. | 2006 Jun 20 |
|
Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. | 2006 Mar |
|
The specific, submicromolar-Km ADP-ribose pyrophosphatase purified from human placenta is enzymically indistinguishable from recombinant NUDT9 protein, including a selectivity for Mn2+ as activating cation and increase in Km for ADP-ribose, both elicited by H2O2. | 2006 Oct |
|
Divalent-metal-dependent nucleolytic activity of Cu, Zn superoxide dismutase. | 2006 Oct |
|
Multivariate analysis of the selected metals in the hair of cerebral palsy patients versus controls. | 2006 Summer |
|
Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. | 2008 |
|
Formation of formal disilene fluoride adducts. | 2008 Dec 24 |
|
Neuronal activity and TrkB ligands influence Kv3.1b and Kv3.2 expression in developing cortical interneurons. | 2008 Oct 15 |
|
High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. | 2009 |
|
Selective demethylation and debenzylation of aryl ethers by magnesium iodide under solvent-free conditions and its application to the total synthesis of natural products. | 2009 Dec 21 |
|
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations. | 2009 Jun 25 |
|
Cardiopulmonary arrest in pregnancy: two case reports of successful outcomes in association with perimortem Caesarean delivery. | 2009 Sep |
|
A rapid three-component MgI(2)-mediated synthesis of 3,3-pyrollidinyl spirooxindoles. | 2010 Oct 1 |
|
C-H functionalization polycondensation of chlorothiophenes in the presence of nickel catalyst with stoichiometric or catalytically generated magnesium amide. | 2011 Jun 29 |
|
Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis. | 2013 |
|
Ofloxacin induces apoptosis via β1 integrin-EGFR-Rac1-Nox2 pathway in microencapsulated chondrocytes. | 2013 Feb 15 |
|
Cascade cyclizations of acyclic and macrocyclic alkynones: studies toward the synthesis of phomactin A. | 2013 Oct 4 |
|
A comparison of oral sulfate solution with sodium picosulfate: magnesium citrate in split doses as bowel preparation for colonoscopy. | 2014 Dec |
|
Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate. | 2015 Feb |
|
MgI2 -mediated chemoselective cleavage of protecting groups: an alternative to conventional deprotection methodologies. | 2015 Jul 27 |
|
Single-day sodium picosulfate and magnesium citrate versus split-dose polyethylene glycol for bowel cleansing prior to colonoscopy: A prospective randomized endoscopist-blinded trial. | 2015 Nov |
|
Polyethylene glycol plus ascorbic acid is as effective as sodium picosulfate with magnesium citrate for bowel preparation: A randomized trial. | 2016 Apr |
|
Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite. | 2016 Jun 15 |
|
High power rechargeable magnesium/iodine battery chemistry. | 2017 Jan 10 |
|
Nano-layered magnesium fluoride reservoirs on biomaterial surfaces strengthen polymorphonuclear leukocyte resistance to bacterial pathogens. | 2017 Jan 5 |
|
MgI(2) -chemoselective cleavage for removal of amino acid protecting groups: A fresh vision for peptide synthesis. | 2017 Mar |
|
Antenatal Exposure to Magnesium Sulfate and Spontaneous Intestinal Perforation and Necrotizing Enterocolitis in Extremely Preterm Neonates. | 2017 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27995243
Curator's Comment: Rats: MgF2 dissolved in acetic acid (Mg=0.08 mM, F=0.084 mM) was delivered in the aerosol form
https://www.ncbi.nlm.nih.gov/pubmed/20647692
Murine osteomyelitis model: medical pure titanium plates in size of 10 mm × 10 mm × 1 mm
were used for the deposition of Magnesium Fluoride (MgF2) film.
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C68264
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
||
|
NDF-RT |
N0000175835
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
||
|
WHO-ATC |
A12CC30
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
||
|
NCI_THESAURUS |
C597
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
||
|
NDF-RT |
N0000175811
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
||
|
NDF-RT |
N0000175834
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000009730
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] | ||
|
DTXSID801020091
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
T6V3LHY838
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
DB01378
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
39127
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
1426853
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
33974
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
T6V3LHY838
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
22537-22-0
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
888
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
C68265
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY | |||
|
18420
Created by
admin on Fri Dec 15 15:59:41 GMT 2023 , Edited by admin on Fri Dec 15 15:59:41 GMT 2023
|
PRIMARY |
ACTIVE MOIETY